Hong Kong Regenerative Medisun Industry and academic circles established under the auspices of the Medisun Medical Group

Medisun launched the “Hong Kong Regenerative Medisun Association”

On May 28, 2018, the Hong Kong Regenerative Medisun Association, which was initiated by representatives from the Hong Kong Regenerative Medisun Industry and academic circles, was formally established under the auspices of the Medisun Medical Group.

Hong Kong Regenerative Medisun Association goals

The Hong Kong Regenerative Medisun Association was founded by experts, scholars, industry representatives and people of insight in the field of regenerative Medisun in Hong Kong and around the world. The purpose of the association is to establish a consensus platform for the regenerative Medisun industry in Hong Kong, promote the development of the regenerative Medisun industry, encourage and promote international cooperation, and propose to the Hong Kong SAR government the recommendations of the regenerative Medisun industry on industry regulations and actively influence industry rules. The establishment and improvement of the company provides effective technical and management advice to the Hong Kong government, Hong Kong public health agencies and companies in the industry.

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

On the afternoon of May 28, representatives from Hong Kong’s medical health, regenerative Medisun and biotechnology fields, doctors, pharmacists, chemists and university researchers gathered to discuss and elect the first council of the Hong Kong Regenerative Medisun Association.They read the charter of the association and clarify the duties of the board. At the same time, they have had a heated discussion on the regulatory documents issued by the Hong Kong SAR Government on Advanced Therapy Products. They agreed to regulate the direction of document guidance and proposed a number of issues that need to be clarified, including:

1. Professional qualifications required by the licensee of the Regenerative Medisun and Stem Cell Research and Development Organization;

2. Advanced Therapy Products is regulated by the Pharmacy and Poisons Ordinance (Cap. 138). However, since the production process and user definition of cellular products and pharmaceutical products are different, they should be clarified accordingly;

3. With reference to the requirements of the international GMP/PICS standard, which standard should be achieved in the cell laboratory qualification of existing regenerative Medisun institutions;

4. After the specific regulation is in force, whether there should be a transition period, so that the industry has time to adjust and cooperate;

5. Submit the Advanced Therapy Products comments and submit them to the Hong Kong Department of Health.

Member of the First Council of the Hong Kong Regenerative Medisun Association

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

Hong Kong Regenerative Medisun Association’s recent work plan

Next, the Hong Kong Regenerative Medisun Association will issue letters to the organizations including the Hong Kong Department of Health, the Hong Kong Stock Exchange, the Hong Kong University Biomedical Science, Life Sciences, and the Global Regenerative Medisun Alliance (ARM). include:

1. Announced the official establishment of the Hong Kong Regenerative Medisun Association

2. Announce the initial membership list of the Hong Kong Regenerative Medisun Council, association charter, association vision and goals

3. Call for the support and participation of experts, scholars and industry representatives from Hong Kong and around the world

4. Propose to the Hong Kong Government to clarify regulatory regulations on Advanced Medisun and Advanced Therapy Products

Special thanks

Thank you for taking the time to attend the representatives of the institutions, including:

For more information, please visit http://www.medisun.hk/

Arabian Crowne – Dubai Condo Hotel

Arabian Crowne will be a luxurious 5 star condo hotel strategically located in the City of Arabia, Dubailand. Towering 45 floors, with 240 incredibly designed and fully furnished units, Arabian Crowne exudes class and luxury. The Arabian Crowne’s contemporary sculptural design creates a landmark destination artfully integrating business and lifestyle opportunities. Its design embraces innovative technology and energy management systems to enhance sustainability. The tower penetrates through a four level podium to create a dynamic public domain at ground level. Sheathed with glazed glass, the façade will offer sweeping views of the City of Arabia and Dubailand, the world’s biggest leisure and retail centre. The proposed monorail will add to the dynamics of development. Read More

Hong Kong Regenerative Medisun Industry and academic circles established under the auspices of the Medisun Medical Group

Medisun launched the “Hong Kong Regenerative Medisun Association”

On May 28, 2018, the Hong Kong Regenerative Medisun Association, which was initiated by representatives from the Hong Kong Regenerative Medisun Industry and academic circles, was formally established under the auspices of the Medisun Medical Group.

Hong Kong Regenerative Medisun Association goals

The Hong Kong Regenerative Medisun Association was founded by experts, scholars, industry representatives and people of insight in the field of regenerative Medisun in Hong Kong and around the world. The purpose of the association is to establish a consensus platform for the regenerative Medisun industry in Hong Kong, promote the development of the regenerative Medisun industry, encourage and promote international cooperation, and propose to the Hong Kong SAR government the recommendations of the regenerative Medisun industry on industry regulations and actively influence industry rules. The establishment and improvement of the company provides effective technical and management advice to the Hong Kong government, Hong Kong public health agencies and companies in the industry.

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

On the afternoon of May 28, representatives from Hong Kong’s medical health, regenerative Medisun and biotechnology fields, doctors, pharmacists, chemists and university researchers gathered to discuss and elect the first council of the Hong Kong Regenerative Medisun Association.They read the charter of the association and clarify the duties of the board. At the same time, they have had a heated discussion on the regulatory documents issued by the Hong Kong SAR Government on Advanced Therapy Products. They agreed to regulate the direction of document guidance and proposed a number of issues that need to be clarified, including:

1. Professional qualifications required by the licensee of the Regenerative Medisun and Stem Cell Research and Development Organization;

2. Advanced Therapy Products is regulated by the Pharmacy and Poisons Ordinance (Cap. 138). However, since the production process and user definition of cellular products and pharmaceutical products are different, they should be clarified accordingly;

3. With reference to the requirements of the international GMP/PICS standard, which standard should be achieved in the cell laboratory qualification of existing regenerative Medisun institutions;

4. After the specific regulation is in force, whether there should be a transition period, so that the industry has time to adjust and cooperate;

5. Submit the Advanced Therapy Products comments and submit them to the Hong Kong Department of Health.

Member of the First Council of the Hong Kong Regenerative Medisun Association

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

Hong Kong Regenerative Medisun Association’s recent work plan

Next, the Hong Kong Regenerative Medisun Association will issue letters to the organizations including the Hong Kong Department of Health, the Hong Kong Stock Exchange, the Hong Kong University Biomedical Science, Life Sciences, and the Global Regenerative Medisun Alliance (ARM). include:

1. Announced the official establishment of the Hong Kong Regenerative Medisun Association

2. Announce the initial membership list of the Hong Kong Regenerative Medisun Council, association charter, association vision and goals

3. Call for the support and participation of experts, scholars and industry representatives from Hong Kong and around the world

4. Propose to the Hong Kong Government to clarify regulatory regulations on Advanced Medisun and Advanced Therapy Products

Special thanks

Thank you for taking the time to attend the representatives of the institutions, including:

For more information, please visit http://www.medisun.hk/

Leading vaccine company born from Profectus Biotech and Medisun Medical Group new joint venture

The famous American vaccine company Profectus settled in Hong Kong

First recommend HPV cervical cancer treatment vaccine

BALTIMORE, MARYLAND, USA and HONG KONG, April 20, 2018

Profectus Biotech and Medisun Medical Group today announced the opening of a new joint venture in Hong Kong. The primary mission of the new company, ProMed BioSciences, Ltd., is to establish a leading vaccine company focused on the development of preventive and therapeutic vaccines for infectious diseases and cancer. The joint venture will leverage Profectus’ vaccine development expertise, clinically proven vaccine platform technology and a developing vaccine product line, in line with Medisun’s expertise, established clinical network and market access capabilities, expected in the second half of 2018 to put into operation.

The company’s first product development program will focus on the development, production and commercial application of prophylactic and therapeutic vaccines for HPV (human papillomavirus)-related lesions and cervical cancer [based on PBSVax® technology developed by Profectus]. ProMed BioSciences also plans to develop and treat hepatitis C virus (HCV), hepatitis B virus (HBV), herpes simplex virus (HSV), respiratory syncytial virus (RSV), and human immunodeficiency virus (HIV). Chikungunya and Zika, as well as personalized vaccines to treat cancer. The joint venture is expected to launch new vaccines in their respective markets, which will help promote the development of new vaccines, but ultimately the goal is to benefit patients around the world.

Mr. Jeffery Meshulam (first from left), President of Profectus Biotechnology, Mr. Terry Lierman (second from left), Chairman of Medivh Medical Group, and Mr. Danny Wong (fourth from right), founder and executive chairman of Medisun Medical Group, at Profectus ,USA.

– Long-term strategic cooperation to address the huge demand for prevention and treatment of infectious diseases and cancer in Asia

-Profectus’ expertise in vaccine development and platform technology, combined with Medisun’s localized expertise and experience, to establish a leading Hong Kong vaccine company focused on serving Asia

“This strategic cooperation will help establish Profectus’ business in Hong Kong and China. Through close cooperation with Medisun, we can assist Hong Kong and China to develop advanced vaccine technology to help prevent and treat Asian patients. Mr. Jeffrey Meshulam, President of Profectus, said, “We are pleased to be able to work with recognized local partners to achieve the highest standards of scientific research and development integration and medical services.”

“This collaboration will help Profectus and Medisun to jointly produce life-saving vaccines for infectious diseases and cancer, and address the huge medical needs that have not been met in Hong Kong, China and Asia.” Mr. Danny Wong, founder and executive chairman of Medisun Medical Group, said “ProMed BioSciences will leverage Profectus’ expertise in vaccine development and technology, combined with Medisun’s local expertise and close links with healthcare facilities in Hong Kong and China, and government medical regulatory agencies to develop vaccines to provide leadership for Asian patients disease prevention and treatment programs.”

ProMed BioSciences will focus on the following:

• Conduct technical research in Hong Kong or China

• Conduct clinical trials in Hong Kong or China

• Promote the expansion of Medisun Medical Center

• Develop vaccines to address disease prevention needs

• leverage to maximize the expertise of both partners

Mr. Jeffery Meshulam, President of Profectus Biotechnology (first from left), Mr. Terry Lierman, Chairman of Medisun Medical Group (first from right), Mr. Danny Wong, founder and executive chairman of Medisun Medical Group (middle), at the US headquarters of  Profectus.

About ProMed BioSciences

ProMed BioSciences Limited is a joint venture between Profectus BioSciences (USA) and Medisun Medical Group (Hong Kong) in Hong Kong to develop and conduct new vaccine clinical trials and commercial applications to address infectious diseases and cancer in Asia with the huge demand for prevention and treatment.

About Medisun

Headquartered in Hong Kong, Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative Medisunne products, as well as quality hospitals and treatment centers. Medisun invests extensively in the fields of regenerative and stem cell patent technology, including stem cell therapy for heart failure, stem cell therapy for liver disease, kidney disease, nervous system disease, cancer, AIDS, and immune cell therapy for a variety of cancers. Medisun and Harvard University Stem Cell Research Institute, Johns Hopkins Medical School Life Science Center, Tsinghua University and other institutions have long-term cooperation plans to jointly invest in regenerative and stem cell therapy technology, with Medisun as a cooperative business The holding entity and holds global intellectual property rights. Medisun and the University of Maryland’s Institute of Human Virology (IHV) set up a technology clinical trial and development platform for viruses and cancer. Based on the Medisun Biomedical Laboratory in Hong Kong, Radiation will jointly build medical clinics in China and Asia. The experimental resource network promotes the world’s largest clinical research and development platform for virus research and cancer treatment technology. The Medisun Reproductive Centre is located at the Proud Square in Kowloon Bay, Hong Kong. It has a 50,000 square foot stem cell GMP production base, a cancer treatment centre and an anti-aging centre. It brings together European, Japanese, American and individual Chinese experts to develop a rigorous and professional R&D process. Provides immune cell therapy and a variety of stem cell health treatments.

For more information, please visit http://www.medisun.hk/

About Profectus BioSciences

Profectus BioSciences is a clinical stage vaccine development company focused on developing new vaccines for infectious disease and cancer prevention and treatment. The Profectus vaccine is based primarily on the company’s proprietary VesiculoVax™ and DNA vaccine technology platform. By simply using the VesiculoVax™ vaccine alone, B cells can be rapidly expanded to provide protection against emerging infectious diseases that threaten public health and biodefense mechanisms, such as Ebola, Marburg, Chikungunya, Zika virus, equine encephalitis virus, and respiratory syncytial virus. When VesiculoVax™ is used as a vaccine when the immune system is launched with the best pDNA vaccine, the Vesiculo Vax™-directed vaccine expands the triggered T cells into effector cells, which are ideal for attacking virus-infected cells and cancer. Current projects using the Prime / Boost Vaccine System (PBS Vax™) strategy include hepatitis B virus (HBV), human papillomavirus (HPV), herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus ( HIV). Partners and collaborators include UTMB’s Galveston National Laboratory, Yale University, University of Maryland Human Virology Institute, HIV/AIDS Vaccine Immunology Center, National Cancer Institute, National Institutes of Health AIDS Division, Bill And the Melinda Gates Foundation, the International AIDS Vaccine Initiative, the AIDS Vaccine Trial Network and the AIDS Clinical Trial Group. Profectus is funded by Cross Atlantic Capital Partners (“XACP”) in Radnor, Pennsylvania. The main investor in XACP is the Pennsylvania Public School Employees Retirement System (“PSERS”). For more information, please visit www.profectusbiosciences.com

Profectus Biotech and Medisun Medical Group new joint venture in Hong Kong

The famous American vaccine company Profectus settled in Hong Kong

First recommend HPV cervical cancer treatment vaccine

BALTIMORE, MARYLAND, USA and HONG KONG, April 20, 2018

Profectus Biotech and Medisun Medical Group today announced the opening of a new joint venture in Hong Kong. The primary mission of the new company, ProMed BioSciences, Ltd., is to establish a leading vaccine company focused on the development of preventive and therapeutic vaccines for infectious diseases and cancer. The joint venture will leverage Profectus’ vaccine development expertise, clinically proven vaccine platform technology and a developing vaccine product line, in line with Medisun’s expertise, established clinical network and market access capabilities, expected in the second half of 2018 to put into operation.

The company’s first product development program will focus on the development, production and commercial application of prophylactic and therapeutic vaccines for HPV (human papillomavirus)-related lesions and cervical cancer [based on PBSVax® technology developed by Profectus]. ProMed BioSciences also plans to develop and treat hepatitis C virus (HCV), hepatitis B virus (HBV), herpes simplex virus (HSV), respiratory syncytial virus (RSV), and human immunodeficiency virus (HIV). Chikungunya and Zika, as well as personalized vaccines to treat cancer. The joint venture is expected to launch new vaccines in their respective markets, which will help promote the development of new vaccines, but ultimately the goal is to benefit patients around the world.

Mr. Jeffery Meshulam (first from left), President of Profectus Biotechnology, Mr. Terry Lierman (second from left), Chairman of Medivh Medical Group, and Mr. Danny Wong (fourth from right), founder and executive chairman of Medisun Medical Group, at Profectus ,USA.

– Long-term strategic cooperation to address the huge demand for prevention and treatment of infectious diseases and cancer in Asia

-Profectus’ expertise in vaccine development and platform technology, combined with Medisun’s localized expertise and experience, to establish a leading Hong Kong vaccine company focused on serving Asia

“This strategic cooperation will help establish Profectus’ business in Hong Kong and China. Through close cooperation with Medisun, we can assist Hong Kong and China to develop advanced vaccine technology to help prevent and treat Asian patients. Mr. Jeffrey Meshulam, President of Profectus, said, “We are pleased to be able to work with recognized local partners to achieve the highest standards of scientific research and development integration and medical services.”

“This collaboration will help Profectus and Medisun to jointly produce life-saving vaccines for infectious diseases and cancer, and address the huge medical needs that have not been met in Hong Kong, China and Asia.” Mr. Danny Wong, founder and executive chairman of Medisun Medical Group, said “ProMed BioSciences will leverage Profectus’ expertise in vaccine development and technology, combined with Medisun’s local expertise and close links with healthcare facilities in Hong Kong and China, and government medical regulatory agencies to develop vaccines to provide leadership for Asian patients disease prevention and treatment programs.”

ProMed BioSciences will focus on the following:

• Conduct technical research in Hong Kong or China

• Conduct clinical trials in Hong Kong or China

• Promote the expansion of Medisun Medical Center

• Develop vaccines to address disease prevention needs

• leverage to maximize the expertise of both partners

Mr. Jeffery Meshulam, President of Profectus Biotechnology (first from left), Mr. Terry Lierman, Chairman of Medisun Medical Group (first from right), Mr. Danny Wong, founder and executive chairman of Medisun Medical Group (middle), at the US headquarters of  Profectus.

About ProMed BioSciences

ProMed BioSciences Limited is a joint venture between Profectus BioSciences (USA) and Medisun Medical Group (Hong Kong) in Hong Kong to develop and conduct new vaccine clinical trials and commercial applications to address infectious diseases and cancer in Asia with the huge demand for prevention and treatment.

About Medisun

Headquartered in Hong Kong, Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative Medisunne products, as well as quality hospitals and treatment centers. Medisun invests extensively in the fields of regenerative and stem cell patent technology, including stem cell therapy for heart failure, stem cell therapy for liver disease, kidney disease, nervous system disease, cancer, AIDS, and immune cell therapy for a variety of cancers. Medisun and Harvard University Stem Cell Research Institute, Johns Hopkins Medical School Life Science Center, Tsinghua University and other institutions have long-term cooperation plans to jointly invest in regenerative and stem cell therapy technology, with Medisun as a cooperative business The holding entity and holds global intellectual property rights. Medisun and the University of Maryland’s Institute of Human Virology (IHV) set up a technology clinical trial and development platform for viruses and cancer. Based on the Medisun Biomedical Laboratory in Hong Kong, Radiation will jointly build medical clinics in China and Asia. The experimental resource network promotes the world’s largest clinical research and development platform for virus research and cancer treatment technology. The Medisun Reproductive Centre is located at the Proud Square in Kowloon Bay, Hong Kong. It has a 50,000 square foot stem cell GMP production base, a cancer treatment centre and an anti-aging centre. It brings together European, Japanese, American and individual Chinese experts to develop a rigorous and professional R&D process. Provides immune cell therapy and a variety of stem cell health treatments.

For more information, please visit http://www.medisun.hk/

About Profectus BioSciences

Profectus BioSciences is a clinical stage vaccine development company focused on developing new vaccines for infectious disease and cancer prevention and treatment. The Profectus vaccine is based primarily on the company’s proprietary VesiculoVax™ and DNA vaccine technology platform. By simply using the VesiculoVax™ vaccine alone, B cells can be rapidly expanded to provide protection against emerging infectious diseases that threaten public health and biodefense mechanisms, such as Ebola, Marburg, Chikungunya, Zika virus, equine encephalitis virus, and respiratory syncytial virus. When VesiculoVax™ is used as a vaccine when the immune system is launched with the best pDNA vaccine, the Vesiculo Vax™-directed vaccine expands the triggered T cells into effector cells, which are ideal for attacking virus-infected cells and cancer. Current projects using the Prime / Boost Vaccine System (PBS Vax™) strategy include hepatitis B virus (HBV), human papillomavirus (HPV), herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus ( HIV). Partners and collaborators include UTMB’s Galveston National Laboratory, Yale University, University of Maryland Human Virology Institute, HIV/AIDS Vaccine Immunology Center, National Cancer Institute, National Institutes of Health AIDS Division, Bill And the Melinda Gates Foundation, the International AIDS Vaccine Initiative, the AIDS Vaccine Trial Network and the AIDS Clinical Trial Group. Profectus is funded by Cross Atlantic Capital Partners (“XACP”) in Radnor, Pennsylvania. The main investor in XACP is the Pennsylvania Public School Employees Retirement System (“PSERS”). For more information, please visit www.profectusbiosciences.com

British Isles sacred locations Travel Tours

Body and Minds Spirit Journeys presents : Three British Isles Tours for you to choose

Scotland, England and Ireland are rich with some of the most magical places of Mother Earth. Now, Body Mind Spirit Journeys invites you to experience three sacred sites tours next Spring.

Ireland: July 11 20, 2018

The Emerald Isle is the land of the faery faith, and this program features ancient stone circles and friendly traditional Irish pubs!

Highlights include:

– Kildare St Brigids Holy Well and St Brigids Cathedral
– Saint Patricks legendary Rock of Cashel
– Lake of Lough Gur, with its fairy wishing seat
– Druid ceremony at Grange Lois, Irelands largest stone circle
– Skellig Michael with its World Heritage 11th century monastery and beehive huts (weather permitting)
– The unspoiled Ring of Kerry and breathtaking Dingle Peninsula
– Magnificent Newgrange, Knowth, Douth and the Hill of Tara

See the Ireland tour details here.

BMSJ can arrange that opportunity for you and assist with every detail.

Dalai LamaWith over 25 years as innovators in the field of sacred and wellness travel, we lead the industry in working with leaders who can bring a group of people together for a common cause and/or travel experience. The only question is, where would you like to go? Many tour hosts with large followings actually earn revenue with their travel programs. Others, hosting the occasional tour, are able to travel free or at a discounted rate, simply by inviting their friends and contacts to travel with them. Whether your group is large or small, BMSJ is happy to walk you through the process and assist you with every step of the way.

More England and Cornwall sacred locations Tours info :

Body Mind Spirit Journeys
P.O. Box 448
Montauk, NY 11954
USA
BMSJ@bodymindspiritjourneys.com

Body Mind Spirit Journeys is a division of RMC Travel.

TagsBritish Isles, England, Spiritual Tourism, travel

LeewayHertz ICO marketing services

We are an end-to-end ICO agency provider for all types of cryptocurrency startups. We do a 2-week sprint with you and your team to kickstart development and marketing efforts to go live and start raising funds. In first 2 weeks, our team develops smart contracts for pre-sale and crowd-sale. In parallel, we develop the website, landing page and also make a custom marketing plan to achieve the goals.

We have partnered with top ICO listing sites, forums, PR sites and therefore guarantee to get your ICO maximum visibility and quick traction. Our support team works round the clock to give you top notch service and answer every query that your investors might ask before being involved with your startup.

Examples of our work :

MyEarthID

Decentralized Identity Management System on the Hedera Hashgraph to solve the global problem of Identity Management. Current identity management process hinders the access to basic and advanced services, like banking, health, insurance, immigration, utilities, etc. due to the common problems of Identity Thefts and Frauds.

LeewayHertz is managing the end to end ICO launch. Starting from Token creation, community management, and marketing, LeewayHertz is working closely with the MyEarthID team to complete a $30M initial coin offering.

Our ICO Services :

Smart Contract for Pre-Sale/Crowd Sale Token

Smart contract definition consist of various attributes Like Ownable, Mintable, Burnable, Transferable Soft Cap, Hard Cap, ICO Date, Bonus, and refund which will be finalized as part of the token definition document

Token Definition Document
Launch smart contract on 2 Test Network
Launch smart contract on Live Network
Github Setup
Result of Testing on test network

Social Media Service

Social Media setup involves setting up a clean and crisp profile with custom graphics and content.

Set up social media accounts
Graphic Assets
Website LIVE
Set up of ticketing system(Zendesk) and config the workflow
Set up the Hotline number

Growth Hack / ICO Marketing Services

Growth hacking is a process of rapid experimentation across marketing channels, and other areas of the business to identify the most efficient ways to grow a community and sales

Digital Strategy
Content Strategy
Influence Marketing
Website Marketing
Campaign Management
Email Marketing
PR & Outreach
Performance Marketing

Contact Details:

Website : https://www.leewayhertz.com/ico-launch-services/
Address:
San Francisco
388 Market Street
Suite 1300
San Francisco, CA 94111
Phone: 877-801-8115
info@leewayhertz.com
jobs@leewayhertz.com

Tagsbusiness, software

Is Robert Berson the 2018 west coast artist manager to watch ?

Every year there are some music producers that just go “BOOM”. Is 2018 Robert Berson’s year? Judging by the success of his managed artists it could very well be. Just watch him closely because there are a lot of signs pointing to a Robert Berson boom year! You can find out more about him on his website Robert Berson – Music Producer Los Angeles.

This Los Angeles based Massachusetts born music producer has played a fundamental part in the creation of many albums, such as: Yellowcards When Youre Through Thinking Say Yes (Acoustic), Ocean Avenue (Acoustic), Punk Goes Rock (Today Cover) and Punk Goes Chritmas (Christmas Lights Cover), Like Torches Keep Your Head High, We The Kings Just Keep Breathing and Find You There, Artist VS Poets among others. With over 20 years of experience in the ever expanding music industry (record production, engineering and song writing), as well as his extensive knowledge of musical equipment used yesterday and today, Robert manages to create the most diverse sound around.

He has worked with the following artists among others: Ryan Key, Cassadee Pope, Travis Clark (We The Kings), Jake Bundrick (Mayday Parade), Sara Mann, BB The Jerk, Rick Thorne, Still Standing, Justin Coppolino, Longineu Parsons II, Dan Lavery (Tonic, The Fray) Tiffany Houghton, Austin Carlile (Of Mice and Men) Tommy Cooperman (it Boys, Breathe Carolina) David Ryan Strauchman (Every Avenue) Liz Hill (Starling Glow), Alex DeLeon (The Cab) Cady Grooves,Nash Overstreet (Hot Chelle Rae), Joe Kirkland (The Voice, AVP) AJ Mclean, Ryan Cabrera, Sean Mackin (Yellowcard), Josh Kelley, Erik Kertes, Paul Doucette (Matchbox Twenty), Jeremy Renner, Edwin McCain, etc. Robert is known for his hard work ethic, positive attitude and respect for the artists vision. Many of his long term work relationships have turned into close friendships.

Robert Berson Management (RB Management) is a talent management company that started by connecting up and coming talent with established professionals. Leveraging Roberts reputation within the music industries he has recently become a full service management company with access to Radio, TV and Film.

Contacts:

Website : http://robertberson.com/
Mailing Address
P.O. Box 691012
Los Angeles, Ca 90069

Twitter: https://twitter.com/robertberson
Instagram: https://www.instagram.com/robertberson/
Facebook: https://www.facebook.com/robert.berson.7

Tagsartist management, entertainment management, music, music producer

Article About “Property Brothers” Star Raises Thorny Questions

U.S. – March. 26, 2018 – Some people have an eye for detail that eludes others and that’s true of writer and freelance researcher, Amy Katz. Her recent article about Jonathan Silver Scott, one of the stars of the “Property Brothers” HGTV series, raises interesting questions and has been receiving a lot of attention.

Katz’s article centers on Scott and his relationship with girlfriend, Jacinta Kuznetsov, a woman he talks about extensively in his memoir “It Takes Two.” In the book, Scott claims he met Kuznetsov briefly at a charity event, but didn’t get her name or contact information. It supposedly took him a month of scouring social media to discover her identity, despite Kuznetsov walking the red carpet and being tagged in numerous photos.

That’s where some readers have cried foul, saying his account of meeting Kuznetsov in the book is at odds with other accounts he gave to the press. Scott commented on Kuznetsov’s social media account four days after the charity event, which would indicate he did, indeed, know her identity long before he claims.

Kuznetsov was formerly the producer of the Canadian music radio talk show, “The Strombo Show,” featuring George Stroumboulopoulos. The Canadian celebrity is a friend of Scott’s and is supposedly the person who finally identified Kuznetsov in a social media photo.

In another account, Scott related that he maintained contact with Kuznetsov after meeting her at the event, a detail that’s in conflict with his version of events in “It Takes Two.” Yet another description of events indicates it was six months before Scott was able to identify her.

The conflicting stories don’t make sense to fans and Katz. They wonder why it was necessary to imbue the couple’s meeting with so much mystery. It’s just one of the reasons that Katz’s article is gaining so much traction.

Before Scott was the host of “Property Brothers,” he was an award-winning magician and illusionist whose accolades at age 16 included 3rd Best State Performer of the Pacific Coast Association of Magicians. For many, the points made in Katz’s article makes them wonder if Scott was exercising his powers of illusion in regard to his relationship with Kuznetsov, and if so, to what end.

Tagsbiz life, property brothers

desarrollo de aplicaciones moviles en Madrid con Yabadabadu.mobi

Huelga decir que todos los propietarios de productos de software quieren crear y lanzar una aplicacin de xito, no la que se pierde en un mar de competencia donde todos luchan por ser el mejor. Aqu hay 11 caractersticas imprescindibles y caractersticas de una aplicacin mvil exitosa, que generalmente no dependen de las caractersticas especficas de los dominios comerciales. La mayora de estas cualidades son aplicables a todas las aplicaciones buenas, y pueden ser fcilmente facilitadas por el equipo dedicado que las crea.

Qu es una buena aplicacin?

La respuesta es bastante simple: es la que satisface completamente las necesidades del usuario final, y lo hace de manera rpida y efectiva, con bastante frecuencia en cuestin de varios toques. Podra hacer una sola cosa, pero hacerlo excepcionalmente bien. Dicho esto, qu hace que una aplicacin sea buena, o incluso la mejor en su nicho? Bueno, adems de un nombre pegadizo e identidad visual. Veamos…

Simplicidad para el usuario final
En otras palabras, significa el desarrollo de una interfaz de usuario conveniente y una navegacin simple, basada en las pautas de diseo para la plataforma seleccionada. Tenga en cuenta la calidad principal de cualquier aplicacin mvil que se encuentre entre las mejores. Si su aplicacin incluye la simplicidad, los usuarios no tendrn ninguna razn para buscar una aplicacin similar. Cualquiera que sea la funcionalidad, cuanto ms fcil se entregue, mejor, y no perder usuarios. Esa es una de las cualidades esenciales que ayudan a las aplicaciones mviles populares a reunir y mantener un pblico fiel. Solo asegrate de elegir un equipo que sepa cmo disear bien una aplicacin.

Tanto iOS como Android deberan estar cubiertos
Estas son dos plataformas esenciales para abarcar. Vale la pena sealar que los marcos modernos de desarrollo de aplicaciones multiplataforma, que incluyen PhoneGap, ReactNative y NativeScript, se han convertido en la solucin de ahorro de costos para la prueba de concepto. El desarrollo multiplataforma ahorra los presupuestos iniciales, permite la entrada temprana en el mercado con un MVP y logra de manera efectiva la siguiente tercera caracterstica …

Alto rendimiento
Su aplicacin mvil debe iniciarse rpidamente por primera vez y nunca debe esperar a los usuarios desde ese momento. Tenga en cuenta que su aplicacin debe optimizarse continuamente, y el alto rendimiento se verificar mediante la garanta de calidad.

Seguridad
Esta caracterstica es vital para el desarrollo de aplicaciones especializadas en industrias tales como la atencin mdica y la administracin de dispositivos mviles, donde la confidencialidad de los datos est protegida en el nivel legal. La provisin de seguridad de datos es una de las tendencias de IoT ms discutidas. Es uno de los requisitos principales discutidos con su equipo.

Trabajo fuera de lnea
Naturalmente, hay muchas aplicaciones que dependen principalmente de la disponibilidad de la conexin an Internet. Sin embargo, el acceso a las funciones y el contenido en modo fuera de lnea es imprescindible incluso en sistemas corporativos complejos. Las caractersticas exactas pueden ser tan especficas que sera difcil categorizarlas.

Actualizaciones regulares
Para obtener una popularidad duradera, necesita un ciclo continuo de desarrollo de productos de software: actualizaciones peridicas y evolucin. Tener un equipo para mantener el servidor. Asegrese de que su contenido est hecho de informacin actualizada y relevante. Actualiza la aplicacin con correcciones y nuevas funciones. Desarrolle su producto, hacindolo ms valioso para sus usuarios.

Comentarios y medios de contacto
Est abierto a todos los usuarios. Crear medios de comunicacin mutua para sugerencias, calificaciones y reseas. Incluya medios de contacto y haga clic para llamar, si es necesario. Haga que todo sea lo ms rpido y simple posible, con un nmero mnimo de toques y un mnimo de ingreso de texto.

Opciones de personalizacin
selo donde sea posible. La personalizacin es innegablemente amada por todos. Las configuraciones, fuentes, colores y tamaos flexibles son un ganador, cuando simplemente se trata de elegir una aplicacin entre otras similares. Deje que sus usuarios vean la aplicacin y funcionen de la manera que deseen. Las emociones positivas pueden inclinar la balanza fcilmente a su favor.

Bsqueda
Crea un sistema intuitivo de bsqueda y filtros especficos. La bsqueda es importante cuando la aplicacin entrega contenido complejo. Sin embargo, no olvides hacer que todas las pginas y todos los servicios sean fcilmente accesibles.

Analtica
Esencial como el aire, esta caracterstica permite rastrear a los usuarios y obtener la informacin completa sobre su comportamiento. As es como puedes medir el xito de tu aplicacin. Puede ver dnde puede mejorarlo durante el desarrollo posterior.

Las aplicaciones se distribuyen a travs de la App Store y de Google Play. Envamos tu APP a las tiendas y optimizamos su SEO personalizando la ficha. Despus, todo lo que tienes que hacer es disfrutar de los beneficios de la distribucin en las tiendas: visibilidad gracias al SEO y garanta de calidad por los comentarios y revisiones de los usuarios.

A menos que hayas renunciado voluntariamente a toda la tecnologa moderna, lo ms probable es que sepas que las Apps se han convertido en un gran tema. De hecho, es incluso difcil imaginar realizar algunas de las tareas diarias sin ellas. Con eso dicho, si tienes una aplicacin en pleno funcionamiento o incluso slo en las etapas iniciales de desarrollo o de planificacin, podras estar en el camino de sacar provecho de los posibles grandes beneficios que la cultura de las aplicaciones ha creado.

Contactar:

# desarrollo de apps mviles en Madrid
# Facebook https://www.facebook.com/yabadabaduinternet
# Twitter https://twitter.com/YabadabaduEs
# Google Plus https://plus.google.com/+YabadabaduEsInternet
# Linkedin https://www.linkedin.com/company/yabadabadu/
# YouTube https://www.youtube.com/user/yabadabaduinternet/

C/ Velzquez, 53 2 Izda. Madrid, Spain
Call +34 911 31 06 33

TagsAndroid Apps, Mobile Apps, Mobile Software, software